ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 208

$1.17M Total Retail Price of All Prescriptions

Rank: 4 out of 208

1,230 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,690 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
ISOSORBIDE MONONITRATE ER 1,026 804 1 10
LISINOPRIL 955 735 2 1
SIMVASTATIN 812 627 3 9
RANEXA 660 441 10 4 22
CARVEDILOL 657 474 5 3
METOPROLOL TARTRATE 393 303 6 2
CLOPIDOGREL 376 271 7 8
AMLODIPINE BESYLATE 371 295 8 5
PRAVASTATIN SODIUM 346 292 9 13
METOPROLOL SUCCINATE 332 290 10 4
HYDROCHLOROTHIAZIDE 332 266 10 18
PLAVIX 319 235 12 12
FUROSEMIDE 317 241 13 6
ZETIA 299 205 14 34
ATORVASTATIN CALCIUM 289 226 15 11
LOSARTAN POTASSIUM 264 220 16 17
FLECAINIDE ACETATE 249 217 17 45
OMEPRAZOLE 244 167 18 28
EFFIENT 225 142 19 36
METOCLOPRAMIDE HCL 217 129 20 111
WARFARIN SODIUM 212 180 21 7
BYSTOLIC 205 150 22 29
SOTALOL 200 194 23 24
XARELTO 196 176 24 53
CRESTOR 191 129 25 15
DIGOXIN 183 133 26 14
DILTIAZEM 24HR CD 182 135 27 40
NIASPAN 177 95 28 41
MULTAQ 177 153 28 46
NEXIUM 176 117 30 47
POTASSIUM CHLORIDE 167 125 31 19
VYTORIN 163 101 32 85
DILTIAZEM 24HR ER 155 125 33 38
PRADAXA 142 135 34 27
SINGULAIR 138 91 35 84
ATENOLOL 125 94 36 16
TRICOR 118 64 37 59
NIFEDIPINE ER 113 113 38 61
NITROSTAT 96 67 39 23
AMLODIPINE BESYLATE-BENAZEPRIL 93 79 40 68
PENTOXIFYLLINE 88 65 41 173
DIOVAN 88 63 41 30
MONTELUKAST SODIUM 85 44 43 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 59 44 37
LIPITOR 81 62 45 48
ISOSORBIDE DINITRATE 79 55 46 75
SPIRONOLACTONE 79 52 46 21
LOSARTAN-HYDROCHLOROTHIAZIDE 77 69 48 43
TEKTURNA 77 69 48 89
FENOFIBRATE 68 48 50 53
PANTOPRAZOLE SODIUM 68 54 50 42
VERAPAMIL ER 67 65 52 86
CARTIA XT 67 65 52 90
BUMETANIDE 64 57 54 44
RAMIPRIL 62 51 55 25
LANSOPRAZOLE 61 34 56 105
TIKOSYN 60 54 57 51
LOVASTATIN 58 44 58 66
PROPAFENONE HCL 57 48 59 60
TRILIPIX 57 28 59 97
COREG CR 54 24 61 121
DILTIAZEM ER 50 30 62 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.